Apoptotic cell death was effectively induced by these two compounds in a flow cytometry assay indicating them as a good inhibitor of human SIRT3. All things considered, this work offers insightful information on the identification and improvement of substances that could function as potent therapeutic agents for SIRT3, presenting encouraging possibilities for the therapy of breast cancer. The gene discussed is SIRT3; the disease is breast carcinoma.